3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Multiple Myeloma
338
Neoplasms, Plasma Cell
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Recurrence
50
Lymphoma
48
Leukemia
39
Neoplasms
27
Lymphoma, Mantle-Cell
27
Burkitt Lymphoma
26
Lymphoma, Large B-Cell, Diffuse
23
Immunoglobulin Light-chain Amyloidosis
23
Lymphoma, Non-Hodgkin
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
17
Leukemia, Lymphocytic, Chronic, B-Cell
16
Hodgkin Disease
14
Nausea
12
Lymphoma, Extranodal NK-T-Cell
12
Lymphoma, B-Cell, Marginal Zone
12
Vomiting
11
Smoldering Multiple Myeloma
11
Prostatic Neoplasms
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Breast Neoplasms
11
Renal Insufficiency
10
Neoplasm Metastasis
9
Lymphoma, Large-Cell, Immunoblastic
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
8
Leukemia, Biphenotypic, Acute
7
Interventions
Rituximab
5
Valganciclovir
3
Zidovudine
2
Methotrexate
2
Leucovorin
2
Doxorubicin
2
merphos
1
cc-486
1
avelumab
1
apatinib
1
Vincristine
1
Valacyclovir
1
Vaccines
1
Tomography, X-Ray Computed
1
Prednisone
1
Nivolumab
1
Kidney Transplantation
1
Interferons
1
Hydroxyurea
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Etoposide
1
Echocardiography
1
EPOCH protocol
1
Docetaxel
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Caves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Epstein-Barr Virus Infections
×
Dexamethasone
×
Clear all
NCT00953420
2017-08-18
CADEN
Baylor College of Medicine
Phase 2
Completed
20 enrolled